These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

563 related articles for article (PubMed ID: 17896972)

  • 1. Sublingual allergen immunotherapy: immunological mechanisms and prospects for refined vaccine preparation.
    O'Hehir RE; Sandrini A; Anderson GP; Rolland JM
    Curr Med Chem; 2007; 14(21):2235-44. PubMed ID: 17896972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allergen-related approaches to immunotherapy.
    Rolland JM; Gardner LM; O'Hehir RE
    Pharmacol Ther; 2009 Mar; 121(3):273-84. PubMed ID: 19111571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subcutaneous immunotherapy suppresses Th2 inflammation and induces neutralizing antibodies, but sublingual immunotherapy suppresses airway hyperresponsiveness in grass pollen mouse models for allergic asthma.
    Hesse L; Brouwer U; Petersen AH; Gras R; Bosman L; Brimnes J; Oude Elberink JNG; van Oosterhout AJM; Nawijn MC
    Clin Exp Allergy; 2018 Aug; 48(8):1035-1049. PubMed ID: 29752757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allergen-specific sublingual immunotherapy for respiratory allergy.
    Passalacqua G; Canonica GW
    BioDrugs; 2001; 15(8):509-19. PubMed ID: 11543692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune mechanisms of allergen-specific sublingual immunotherapy.
    Moingeon P; Batard T; Fadel R; Frati F; Sieber J; Van Overtvelt L
    Allergy; 2006 Feb; 61(2):151-65. PubMed ID: 16409190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sublingual immunotherapy: an update on immunologic and functional effects.
    Ciprandi G; Fenoglio D; Cirillo I; Tosca MA; La Rosa M; Licari A; Marseglia A; Barberi S; Marseglia GL
    Allergy Asthma Proc; 2007; 28(1):40-3. PubMed ID: 17390756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maintenance-Phase Subcutaneous Immunotherapy with House Dust Mites Induces Cyclic Immunologic Effects.
    Chaoul N; Albanesi M; Giliberti L; Rossi MP; Nettis E; Di Bona D; Caiaffa MF; Macchia L
    Int Arch Allergy Immunol; 2019; 179(1):37-42. PubMed ID: 30921804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sublingual grass pollen immunotherapy is associated with increases in sublingual Foxp3-expressing cells and elevated allergen-specific immunoglobulin G4, immunoglobulin A and serum inhibitory activity for immunoglobulin E-facilitated allergen binding to B cells.
    Scadding GW; Shamji MH; Jacobson MR; Lee DI; Wilson D; Lima MT; Pitkin L; Pilette C; Nouri-Aria K; Durham SR
    Clin Exp Allergy; 2010 Apr; 40(4):598-606. PubMed ID: 20184605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological mechanisms of sublingual immunotherapy.
    Akdis CA; Barlan IB; Bahceciler N; Akdis M
    Allergy; 2006; 61 Suppl 81():11-4. PubMed ID: 16792600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real-life compliance and persistence among users of subcutaneous and sublingual allergen immunotherapy.
    Kiel MA; Röder E; Gerth van Wijk R; Al MJ; Hop WC; Rutten-van Mölken MP
    J Allergy Clin Immunol; 2013 Aug; 132(2):353-60.e2. PubMed ID: 23651609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sublingual immunotherapy: from biological extracts to recombinant allergens.
    Moingeon P
    Allergy; 2006; 61 Suppl 81():15-9. PubMed ID: 16792601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucosal immunization application to allergic disease: sublingual immunotherapy.
    Frati F; Moingeon P; Marcucci F; Puccinelli P; Sensi L; Di Cara G; Incorvaia C
    Allergy Asthma Proc; 2007; 28(1):35-9. PubMed ID: 17390755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T cell targeted strategies for improved efficacy and safety of specific immunotherapy for allergic disease.
    Rolland JM; Prickett S; Gardner LM; O'Hehir RE
    Antiinflamm Antiallergy Agents Med Chem; 2013; 12(3):201-22. PubMed ID: 23597085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two year follow-up of immunological response in mite-allergic children treated with sublingual immunotherapy. Comparison with subcutaneous administration.
    Antúnez C; Mayorga C; Corzo JL; Jurado A; Torres MJ
    Pediatr Allergy Immunol; 2008 May; 19(3):210-8. PubMed ID: 18399897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcutaneous delivery of CpG-adjuvanted allergen via laser-generated micropores.
    Hessenberger M; Weiss R; Weinberger EE; Boehler C; Thalhamer J; Scheiblhofer S
    Vaccine; 2013 Jul; 31(34):3427-34. PubMed ID: 23273971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subcutaneous and Sublingual Immunotherapy in a Mouse Model of Allergic Asthma.
    Hesse L; Nawijn MC
    Methods Mol Biol; 2017; 1559():137-168. PubMed ID: 28063043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allergen immunotherapy in allergic respiratory diseases: from mechanisms to meta-analyses.
    Viswanathan RK; Busse WW
    Chest; 2012 May; 141(5):1303-1314. PubMed ID: 22553263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allergen-specific Immunotherapy for Inhalant Allergens in Children.
    Caffarelli C; Cangemi J; Mastrorilli C; Giannetti A; Ricci G
    Curr Pediatr Rev; 2020; 16(2):129-139. PubMed ID: 31642784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences and similarities between sublingual immunotherapy of allergy and oral tolerance.
    Moingeon P; Mascarell L
    Semin Immunol; 2017 Apr; 30():52-60. PubMed ID: 28760498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allergen immunotherapy: past, present and future.
    Durham SR; Shamji MH
    Nat Rev Immunol; 2023 May; 23(5):317-328. PubMed ID: 36253555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.